Omicron Unlikely to Cause Severe Illness in Vaccinated People, BioNTech Says 

The variant could lead to more infections among vaccinated people but they will most likely remain protected from a severe course of illness, according to the inventor of one of the first Covid-19 vaccines.

Merck's Covid-19 Pill Under Review by FDA Advisers 

The panel's endorsement of the antiviral molnupiravir, from Merck and partner Ridgeback, could open the door for FDA authorization before the end of the year.

Pfizer Vaccine Executive Moves to Rival GlaxoSmithKline 

The high-profile industry move comes as Pfizer and other vaccine makers scramble to assess how their shots will stand up to a new variant of the coronavirus that causes Covid-19.

Facebook Parent Told to Sell Giphy by U.K. Regulator 

The U.K.'s top competition regulator directed Meta Platforms, formerly Facebook, to sell social-media animated-images company Giphy, saying its acquisition could limit competition among platforms and U.K. advertisers.

Glencore Faces Call From Activist to Sell Coal Assets 

The commodities giant is the last of the world's large miners to retain a presence in thermal coal, a currently lucrative business but one seen by some as harmful to the environment.

Zara Parent Elevates Founder's Daughter to Chairwoman 

Zara's parent company said it had appointed the daughter of the retailer's founder as its new chairwoman, placing a little-known 37-year-old atop one of the world's largest fashion chains.

KKR, Wells Fargo Look to Expand at Manhattan's Hudson Yards 

High-end office space-with amenities such as outdoor terraces, game rooms and superior ventilation systems-is still in demand as companies try to lure back remote workers and retain talent.

Aeromexico Creditors Lobby Airline's Backer Delta Over Bankruptcy Exit Plan 

Grupo Aeroméxico is roiling some of its creditors with a restructuring plan that sets aside an ownership stake for its partner and part-owner Delta Air Lines while paying a fraction of some of its debts.

SoftBank Bets on Asian Metaverse Platform Selling Digital Gucci, Dior 

SoftBank is investing $150 million in a South Korean platform that has amassed a large following of young female users by selling high fashion for 3-D avatars.

Covid Antibody Drugs Challenged by Omicron 

Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant, a sign that some therapies might need modifying.


(END) Dow Jones Newswires

November 30, 2021 11:15 ET (16:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.